Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-26

Clinical Trial Update: Endocan, VEGF and TNF-alpha Levels in Periodontal Disease and After Treatment

View source ↗

Summary

A completed clinical trial evaluating biomarker levels Endocan, VEGF, and TNF-alpha in periodontal disease before and after treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bulent Ecevit University | Conditions: Periodontal Disease | Status: COMPLETED